2 results
Not approvedWill not start
To compare the EPOS guideline with the free choice treatment of the GP for acute rhinosinusitis in general practice.
Approved WMORecruiting
The purpose of this Phase II/III study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RO7204239, a humanized monoclonal antibody that binds to human latent myostatin, in combination with risdiplam (…